Clinical Trial Update: A Study of MK-6552 in Sleep Deprived Healthy Participants (MK-6552-003) [Phase 1]

View source ↗

Summary

This Phase 1 trial of MK-6552 (MK-6552-003) in sleep-deprived healthy participants and participants with narcolepsy has completed, with Merck Sharp & Dohme LLC …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy

Drugs mentioned

• MK-6552

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Healthy, Narcolepsy | Phase 1 | Status: COMPLETED